- Aptorum published its annual report on Form 20-F for the fiscal year ended Dec. 31, 2025, reporting a net loss of USD 1.38 million.
- Total operating expenses were USD 1.82 million, down 53.88%, including research and development expenses of USD 352,879, down 83.93%.
- Legal and professional fees rose 32.25% to USD 1.06 million, which the company attributed to non-routine activities including potential merger activity.
- Net cash used in operating activities was USD 1.84 million, up 54.37%, which was attributed to lower government grant receipts after pausing the majority of R&D activities.
- Management said it paused the majority of R&D to focus on completing the planned merger with DiamiR and continues to explore other reverse takeover or business combination opportunities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptorum Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-035484), on March 27, 2026, and is solely responsible for the information contained therein.